Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-070884
Filing Date
2026-06-23
Accepted
2026-06-23 09:28:27
Documents
47
Period of Report
2026-06-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0295622-6k_purple.htm 6-K 9340
2 PURPLE BIOTECH CORPORATE PRESENTATION JUNE 2026 ea029562201ex99-1.htm EX-99.1 67531
3 GRAPHIC ea029562201_ex99-1img1.jpg GRAPHIC 298668
4 GRAPHIC ea029562201_ex99-1img2.jpg GRAPHIC 652392
5 GRAPHIC ea029562201_ex99-1img3.jpg GRAPHIC 273340
6 GRAPHIC ea029562201_ex99-1img4.jpg GRAPHIC 248864
7 GRAPHIC ea029562201_ex99-1img5.jpg GRAPHIC 362177
8 GRAPHIC ea029562201_ex99-1img6.jpg GRAPHIC 327448
9 GRAPHIC ea029562201_ex99-1img7.jpg GRAPHIC 296873
10 GRAPHIC ea029562201_ex99-1img8.jpg GRAPHIC 244074
11 GRAPHIC ea029562201_ex99-1img9.jpg GRAPHIC 284701
12 GRAPHIC ea029562201_ex99-1img10.jpg GRAPHIC 216719
13 GRAPHIC ea029562201_ex99-1img11.jpg GRAPHIC 334363
14 GRAPHIC ea029562201_ex99-1img12.jpg GRAPHIC 267214
15 GRAPHIC ea029562201_ex99-1img13.jpg GRAPHIC 387230
16 GRAPHIC ea029562201_ex99-1img14.jpg GRAPHIC 369076
17 GRAPHIC ea029562201_ex99-1img15.jpg GRAPHIC 355637
18 GRAPHIC ea029562201_ex99-1img16.jpg GRAPHIC 219385
19 GRAPHIC ea029562201_ex99-1img17.jpg GRAPHIC 369848
20 GRAPHIC ea029562201_ex99-1img18.jpg GRAPHIC 359980
21 GRAPHIC ea029562201_ex99-1img19.jpg GRAPHIC 372810
22 GRAPHIC ea029562201_ex99-1img20.jpg GRAPHIC 236311
23 GRAPHIC ea029562201_ex99-1img21.jpg GRAPHIC 258093
24 GRAPHIC ea029562201_ex99-1img22.jpg GRAPHIC 262946
25 GRAPHIC ea029562201_ex99-1img23.jpg GRAPHIC 329532
26 GRAPHIC ea029562201_ex99-1img24.jpg GRAPHIC 227652
27 GRAPHIC ea029562201_ex99-1img25.jpg GRAPHIC 273541
28 GRAPHIC ea029562201_ex99-1img26.jpg GRAPHIC 221711
29 GRAPHIC ea029562201_ex99-1img27.jpg GRAPHIC 281369
30 GRAPHIC ea029562201_ex99-1img28.jpg GRAPHIC 176584
31 GRAPHIC ea029562201_ex99-1img29.jpg GRAPHIC 257264
32 GRAPHIC ea029562201_ex99-1img30.jpg GRAPHIC 398716
33 GRAPHIC ea029562201_ex99-1img31.jpg GRAPHIC 279981
34 GRAPHIC ea029562201_ex99-1img32.jpg GRAPHIC 299422
35 GRAPHIC ea029562201_ex99-1img33.jpg GRAPHIC 352630
36 GRAPHIC ea029562201_ex99-1img34.jpg GRAPHIC 406376
37 GRAPHIC ea029562201_ex99-1img35.jpg GRAPHIC 332104
38 GRAPHIC ea029562201_ex99-1img36.jpg GRAPHIC 423664
39 GRAPHIC ea029562201_ex99-1img37.jpg GRAPHIC 385433
40 GRAPHIC ea029562201_ex99-1img38.jpg GRAPHIC 274415
41 GRAPHIC ea029562201_ex99-1img39.jpg GRAPHIC 406011
42 GRAPHIC ea029562201_ex99-1img40.jpg GRAPHIC 269880
43 GRAPHIC ea029562201_ex99-1img41.jpg GRAPHIC 336378
44 GRAPHIC ea029562201_ex99-1img42.jpg GRAPHIC 417429
45 GRAPHIC ea029562201_ex99-1img43.jpg GRAPHIC 335435
46 GRAPHIC ea029562201_ex99-1img44.jpg GRAPHIC 410019
47 GRAPHIC ea029562201_ex99-1img45.jpg GRAPHIC 181287
  Complete submission text file 0001213900-26-070884.txt   19518638
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 261109202
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)